Lupin launches Fluocinonide Ointment USP 0.05%

March 29, 2019 | Friday | News

It is the generic version of County Line Pharmaceuticals LLC’s Lidex® Ointment 0.05%.

Lupin announced the launch of Fluocinonide Ointment USP, 0.05%, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Fluocinonide Ointment USP, 0.05%, is the generic version of County Line Pharmaceuticals LLC’s Lidex® Ointment 0.05%.

It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Fluocinonide Ointment USP, 0.05% had annual sales of approximately USD 15 million in the U.S (IQVIA MAT January 2019).